-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Titan Medical Inc. (NASDAQ:TMDI) Shares Bought by Essex LLC
Titan Medical Inc. (NASDAQ:TMDI) Shares Bought by Essex LLC
Essex LLC lifted its holdings in shares of Titan Medical Inc. (NASDAQ:TMDI – Get Rating) by 17.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,364,218 shares of the company's stock after buying an additional 359,581 shares during the period. Essex LLC's holdings in Titan Medical were worth $1,064,000 at the end of the most recent reporting period.
Separately, JPMorgan Chase & Co. raised its stake in shares of Titan Medical by 70.9% during the 1st quarter. JPMorgan Chase & Co. now owns 126,600 shares of the company's stock worth $67,000 after buying an additional 52,500 shares during the period. Institutional investors own 3.55% of the company's stock.
Get Titan Medical alerts:Titan Medical Trading Up 4.6 %
Shares of TMDI stock traded up $0.04 during trading hours on Friday, hitting $0.88. 212,696 shares of the company's stock were exchanged, compared to its average volume of 432,199. The firm has a 50 day moving average of $0.73 and a two-hundred day moving average of $0.57. Titan Medical Inc. has a fifty-two week low of $0.38 and a fifty-two week high of $1.20.
Titan Medical (NASDAQ:TMDI – Get Rating) last announced its earnings results on Thursday, November 10th. The company reported ($0.09) earnings per share for the quarter.About Titan Medical
(Get Rating)
Titan Medical, Inc engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.
See Also
- Get a free copy of the StockNews.com research report on Titan Medical (TMDI)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Want to see what other hedge funds are holding TMDI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Titan Medical Inc. (NASDAQ:TMDI – Get Rating).
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Essex LLC lifted its holdings in shares of Titan Medical Inc. (NASDAQ:TMDI – Get Rating) by 17.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,364,218 shares of the company's stock after buying an additional 359,581 shares during the period. Essex LLC's holdings in Titan Medical were worth $1,064,000 at the end of the most recent reporting period.
埃塞克斯有限責任公司在泰坦醫療公司的股份持有權 (NASDAQ: TMDI — 獲得評級) 17.9% 在第三季度, 控股渠道報告.該機構投資者在期內額外購買 359,581 股股票後，擁有該公司股票 2,364,218 股股份。在最近的報告期結束時，埃塞克斯有限責任公司在泰坦醫療的持股價值為 1,064,000 美元。
Separately, JPMorgan Chase & Co. raised its stake in shares of Titan Medical by 70.9% during the 1st quarter. JPMorgan Chase & Co. now owns 126,600 shares of the company's stock worth $67,000 after buying an additional 52,500 shares during the period. Institutional investors own 3.55% of the company's stock.
此外，摩根大通公司於第一季度增加了其在泰坦醫療股份的股份股份的股份權益 70.9%。在期內，摩根大通公司現在擁有該公司股票的 126,600 股，價值 67,000 美元。機構投資者擁有公司股票的 3.55%。
Titan Medical Trading Up 4.6 %
泰坦醫療交易上升 4.6%
Shares of TMDI stock traded up $0.04 during trading hours on Friday, hitting $0.88. 212,696 shares of the company's stock were exchanged, compared to its average volume of 432,199. The firm has a 50 day moving average of $0.73 and a two-hundred day moving average of $0.57. Titan Medical Inc. has a fifty-two week low of $0.38 and a fifty-two week high of $1.20.
TMDI 股票在周五交易時間內上漲 0.04 美元，觸及 0.88 美元。該公司股票的交易量為 212,696 股，而該公司股票的平均成交量為 432,199 股。該公司的 50 日移動平均線為 0.73 美元，兩百日移動平均線為 0.57 美元。泰坦醫療公司擁有五十兩周低點 0.38 美元，五十二周高點為 1.20 美元。
About Titan Medical
關於泰坦醫療
(Get Rating)
(取得評分)
Titan Medical, Inc engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.
泰坦醫療股份有限公司從事計算機輔助機器人手術技術的研究和開發，用於微創手術（MIS）中的應用。它的產品組合是 Eos 系統，是一種機器人單一進出手術，具有雙 3D 和 2D 定義視覺系統，多重關節儀器和一個外科醫生工作站。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Titan Medical (TMDI)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 獲取有關泰坦醫療研究報告的免費副本
- 市場節拍週的回顧 — 1/23-1/27
- 為什麼清醒在一天內飆升近 100％
- 乘坐這些鐵路股票以獲得增長和收入
- ASML 今年看到籌碼需求上升，提高了銷售觀點
- KLA 公司：陷入困境的半市場中的實力
Want to see what other hedge funds are holding TMDI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Titan Medical Inc. (NASDAQ:TMDI – Get Rating).
想看看還有哪些對沖基金持有 TMDI？ 訪問 Holdingschannel.com 以獲取泰坦醫療公司（NASDAQ：TMDI-獲取評級）的最新 13 樓文件和內幕交易。
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收泰坦醫療日報的最新消息和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Titan Medical 和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧